Search Within

Elizabeth Hoover

Formats
  1. Meeting Abstract (25)
  2. Journal Article (5)
Groups
  1. Bone Marrow Transplant (30)
  2. Center for Hematologic Malignancies (30)
  3. Department of Medicine (30)
  4. Hematologic Malignancies, Division of (30)
  5. Survivorship Research (28)
  6. Myeloma (21)

More Groups

People
  1. Heather Landau (26)
  2. Hani Hassoun (20)
  3. Sergio Giralt (15)
  4. David Chung (12)
  5. Elyn Stubblefield (11)
  6. Alexander Lesokhin (10)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (4)

More Years

Publications
  1. Blood (10)
  2. Biology of Blood and Marrow Transplantation (7)
  3. Clinical Lymphoma, Myeloma and Leukemia (4)
  4. Amyloid (2)
  5. Journal of Clinical Oncology (2)
  6. Leukemia and Lymphoma (2)

More Publications

Publishers
  1. Elsevier Inc. (12)
  2. American Society of Hematology (10)
  3. Taylor & Francis Group (4)
  4. American Society of Clinical Oncology (2)
  5. American Association for Cancer Research (1)
  6. Nature Publishing Group (1)

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM)
    Meeting Abstract

    Shah, G.; Holder, J.; Cho, S.; Murata, K.; Devlin, S.; Hoover, E.; Chung, D.; Dahi, P.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation
    Journal Article

    Landau, H.; Wood, K.; Chung, D. J.; Koehne, G.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hoover, E.; Zheng, J. T.; Devlin, S. M.; more...
    Leukemia and Lymphoma (2016)

    Fulltext@MSK | Save
  • Leveraging technology and education improves acute graft-versus-host disease assessment and data capture
    Meeting Abstract

    Dierov, D.; Hilden, P.; Ponce, D. M.; Prockop, S. E.; Featherstone, C.; Wills, J.; Devlin, S. M.; Collum, K.; Ciolino, C.; Garfinkle, R.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Induction with bortezomib and dexamethasone (BD) followed by risk adapted high dose melphalan and autologous stem cell transplantation and BD consolidation in patients with AL amyloidosis: A phase II feasibility study
    Meeting Abstract

    Landau, H.; Montanez, N.; Cowan, A.; Hoover, E.; Flombaum, C.; Liu, J.; Maurer, M.; Lendvai, N.; Landgren, O.; Giralt, S. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
    Journal Article

    Landau, H.; Hassoun, H.; Rosenzweig, M. A.; Maurer, M.; Liu, J.; Flombaum, C.; Bello, C.; Hoover, E.; Riedel, E.; Giralt, S.; more...
    Leukemia (2013)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with multiple myeloma undergoing autologous stem cell transplant
    Meeting Abstract

    Wood, K.; Giralt, S. A.; Koehne, G.; Chung, D.; Hassoun, H.; Lendvai, N.; Lesokhin, A.; Hoover, E.; Devlin, S.; Landau, H.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with multiple myeloma undergoing autologous stem cell transplant
    Meeting Abstract

    Wood, K.; Giralt, S. A.; Koehne, G.; Chung, D.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hoover, E.; Devlin, S.; Landau, H.
    Blood (2012)

    Fulltext@MSK | Save
  • Maintained hematologic and organ responses following risk adapted stem cell transplant (SCT) in systemic light-chain amyloidosis (AL) using bortezomib and dexamethasone as consolidation therapy
    Meeting Abstract

    Landau, H. J.; Hassoun, H.; Rosenzweig, M. A.; Bello, C.; Hoover, E.; Riedel, E.; Comenzo, R. L.
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save